-
He argues that because of the potential for heart attacks and other risks, including cases of heart failure and broken bones, Avandia should be yanked.
FORBES: What Did Glaxo Know?
-
If the findings hold up, they could open a totally new approach to heart disease, with the potential to slash heart attacks far beyond the 30%-to-40% reduction seen with cholesterol-lowering drugs alone.
FORBES: Prevention Puzzle
-
Here's a deeper irony: The FDA had not only missed the opportunity to make a statement about a potential link between Avandia and heart attacks, even if only to dismiss it.
FORBES: Averting Another Avandia?